The endometrial cancer data from the ATAC (arimidex, tamoxifen, alone or in combination) trial indicates a protective effect of anastrozole (arimidex) upon the endometrium

被引：0

|

作者：

Duffy, SR

Greenwood, M

机构：

[1] AstraZeneca, Alderley Pk, England

[2] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

134

引用

收藏

页码：S29 / S29

页数：1

相关论文

共 50 条

[21] The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) women.
Baum, M
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 210 - 210
[22] Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial
Fallowfield, L
Cella, D
Cuzick, L
Francis, S
Locker, G
Howell, A
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4261 - 4271
[23] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
Baum, M
Dowsett, M
Coibion, M
Bianco, AR
Cuzick, J
George, WD
Gray, J
Howell, A
Houghton, J
Williams, N
Sloane, J
Tobias, J
Buzdar, A
Anderson, MD
Jackson, I
Sahmoud, T
Gallagher, J
Webster, A
Gangji, D
Petrakova, K
Konopasek, B
Mares, P
Vodvarka, P
Alcazar, A
Campos, O
Maxwell, A
Goedhals
Hacking, D
Landers, G
Smith, L
Vorobiof, DA
Werner, ID
Blamey, R
Coleman, R
Grieve, RJ
Hickish, T
Howell, A
Nicholls, JC
Nicholson, S
Raymond, S
Salman, A
Blum, J
Clark, R
Lyss, A
Miletello, G
Sternberg, J
Forbes, J
Coibion, M
Nabholtz, JM
Guastalla, JP
BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 317 - 324
[24] Beneficial side-effect profile of anastrozole compared with tamoxifen confirmed by additional 7 months of exposure data: a safety update from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial
Sainsbury, R
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
[25] Efficacy data from the ATAC ("arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment
不详
BREAST, 2005, 14 : S51 - S51
[26] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
British Journal of Cancer, 2001, 85 : 317 - 324
[27] Impact of age on gynaecological adverse events: data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial on behalf of the ATAC Trialists' Group
Disller, Wolfgang
ANNALS OF ONCOLOGY, 2004, 15 : 64 - 65
[28] Clinical features of joint symptoms observed in the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial.
Buzdar, A. U.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 15S - 15S
[29] Tolerability of anastrozole (A) compared with tamoxifen (T): Mature data in the adjuvant setting - Data reported on behalf of the ATAC ('arimidex', tamoxifen, alone or in combination) trialists' group
Mansel, Robert
ANNALS OF ONCOLOGY, 2006, 17 : 94 - 94
[30] Fewer gynaecological adverse events (AEs), gynaecological interventions, endometrial changes and abnormalities with anastrozole than with tamoxifen: findings from the ATAC ('Arimidex', Tarmoxifen, Alone or in Combination) trial
Distler, W.
BREAST, 2007, 16 : S45 - S46

← 1 2 3 4 5 →